PRKDC and neoplasm: Our data further reveal that the molecular determinants of the activation of DNA‐PK‐dependent signaling are governed by cell‐type specific rules, that, if adequately harnessed, may allow targeting inflammatory responses in specific cells of the tumor microenvironment.